Advertisement

Neopterin, Interferon-γ, and Immunodeficiency States

  • D. Fuchs
  • A. Hausen
  • G. Reibnegger
  • G. Weiss
  • E. R. Werner
  • G. Werner-Felmayer
  • H. Wachter

Abstract

Concentrations of neopterin (D-erythro-6-trihydroxypropylpterin) in body fluids indicate the activation of cellular immunity in patients. In vitro, human macrophages release large amounts of neopterin on stimulation with interferon-γ (IFN-γ) [1,8]. Other cytokines, e.g., tumour necrosis factor-α (TNF-α) are capable of further enhancing the IFN-γ-induced formation of neopterin. Neopterin concentrations correlate with the extent and the activity of disorders in which cell-mediated immune stimulation has a role (Table 1). In allograft recipients, neopterin concentrations rise early during the course of rejection episodes. Increasing neopterin is among the first signs of infections by viruses, occurring days or weeks before antibody seroconversion becomes measurable. In autoimmune disorders such as rheumatoid arthritis, neopterin levels correlate with the extent and activity of the disease. Neopterin levels are of predictive significance in patients with, for example, certain types of malignancy, multiple trauma, and human immunodeficiency virus (HIV) infection.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Type Multiple Trauma Chronic Inflammatory Disorder Neopterin Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H (1988) Neopterin as a marker for activated cell-mediated immunity: application in HIV-1 infection. Immunol Today 9:150–155PubMedCrossRefGoogle Scholar
  2. 2.
    Fuchs D, Malkowsky M, Reibnegger G, Werner ER, Forni G, Wachter H (1989) Endogenous release of interferon gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Lett 23:103–108PubMedCrossRefGoogle Scholar
  3. 3.
    Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J AIDS 3:873–876Google Scholar
  4. 4.
    Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H (1991) Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 46:65–70PubMedCrossRefGoogle Scholar
  5. 5.
    Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H (1991) Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett (in press)Google Scholar
  6. 6.
    Robin B, Fuchs D, Koller W, Wachter H (1991) Course of immune activation markers in patients after severe multiple trauma. Pteridines (in press)Google Scholar
  7. 7.
    Strohmaier W, Redl H, Schlag G, Inthorn D (1987) D-erythroneopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 15:757–760PubMedCrossRefGoogle Scholar
  8. 8.
    Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER (1989) Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27:81–141PubMedCrossRefGoogle Scholar
  9. 9.
    Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H (1987) Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci 41:273–280PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1993

Authors and Affiliations

  • D. Fuchs
    • 1
    • 2
  • A. Hausen
    • 1
    • 2
  • G. Reibnegger
    • 1
    • 2
  • G. Weiss
    • 1
    • 2
  • E. R. Werner
    • 1
    • 2
  • G. Werner-Felmayer
    • 1
    • 2
  • H. Wachter
    • 1
    • 2
  1. 1.Institut für Medizinische Chemie und BiochemieUniversität InnsbruckInnsbruckAustria
  2. 2.Ludwig Boltzmann Institut für AIDS-ForschungInnsbruckAustria

Personalised recommendations